Albuminuria and Diabetes Predict Worse Outcomes in HFpEF Patients, finds study Dr Riya Dave11 April 2025 9:00 AM ISTResearchers have established that both diabetes mellitus (DM) and albuminuria are prevalent in heart failure with preserved ejection fraction (HFpEF)...
Rise in kidney disease underscores critical heart-kidney connection: Study Dr. Kamal Kant Kohli10 April 2025 8:45 PM ISTGlobally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart...
FDA Grants Accelerated Approval to Atrasentan for IgA Nephropathy Dr. Kamal Kant Kohli5 April 2025 9:30 AM ISTThe US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary immunoglobulin A (IgA)...
Medical Bulletin 03/ April/ 2025 Dr. Bhumika Maikhuri3 April 2025 3:00 PM ISTHere are the top health news for the day:Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human...
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure Dr. Bhumika Maikhuri3 April 2025 8:15 AM ISTThe drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...
FDA Approves First oral Treatment for rare Glomerulopathy Dr. Kamal Kant Kohli22 March 2025 6:30 AM ISTThe US Food and Drug Administration (FDA) has approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3...
Addition of Metformin to SGLT2 Inhibitors Lowers Kidney Disease Risk in Diabetes Patients: Study Dr Riya Dave14 March 2025 9:00 AM ISTResearchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a significant reduction in...
Lipoprotein (a) risk factor and potential target for Chronic Kidney Disease, unravels study Dr.Niharika Harsha B25 Feb 2025 8:15 PM ISTA recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause chronic kidney disease...
Sotagliflozin significantly lowers Heart Attack and Stroke Risk, reports Lancet study Dr. Kamal Kant Kohli20 Feb 2025 9:00 AM ISTSotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular risk factors, has been...
Yo-yo dieting may significantly increase kidney disease risk in people with type 1 diabetes, unravels study Dr. Kamal Kant Kohli13 Feb 2025 9:00 AM ISTBody-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes,...
How novel antibody felzartamab impacts IgA nephropathy? Dr. Kamal Kant Kohli3 Feb 2025 8:30 PM ISTIgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2...
FDA approves Semaglutide for renal protection among diabetes patients with CKD Dr. Kamal Kant Kohli30 Jan 2025 9:00 AM ISTNovo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
